WHO ICTRP trial
A 52-Week, Multinational, Multi-Centre, Open-Labelled Extension Trial of Insulin…
EUCTR2006-002478-23-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-002478-23-GB |
|---|---|
| Public title | A 52-Week, Multinational, Multi-Centre, Open-Labelled Extension Trial of Insulin Detemir in Children and Adolescents 3-17 years with Type 1 Diabetes on a Basal- Bolus Regimen with Insulin Aspart as Bolus Insulin Trial Phase: 3b |
| Scientific title | A 52-Week, Multinational, Multi-Centre, Open-Labelled Extension Trial of Insulin Detemir in Children and Adolescents 3-17 years with Type 1 Diabetes on a Basal- Bolus Regimen with Insulin Aspart as Bolus Insulin Trial Phase: 3b |
| Primary sponsor | Novo Nordisk A/S |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | France;Czech Republic;Hungary;Finland;Denmark;Bulgaria;United Kingdom |
| Conditions | Type 1 Diabetes MedDRA version: 8.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus |
| Interventions | Trade Name: Levemir Product Name: Levemir Pharmaceutical Form: Solution for injection INN or Proposed INN: Insulin detemir CAS Number: NN304 Concentration unit: IU/ml international unit(s)/millilitre Concentration type: equal Concentration… |
| Registration date | Jan 8, 2007 |
| Target size | 120 |
| Secondary IDs | NN304-1690 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: